Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,150,530
+$310,165 QoQ
Shares Held
41,025
+23.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#250
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SATURNA CAPITAL CORP holds $1,106,352,364 across 8 Drug Manufacturers - General names. GSK ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
460,411 | $552,230,811 | |
| 2 | ABBV |
AbbVie Inc.
|
958,069 | $241,088,483 | |
| 3 | AZN |
Astrazeneca PLC
|
911,933 | $172,920,735 | |
| 4 | JNJ |
Johnson & Johnson
|
229,115 | $58,188,336 | |
| 5 | NVS |
Novartis AG
|
311,392 | $48,801,354 | |
| 6 | MRK |
Merck & Co., Inc.
|
197,643 | $25,397,125 | |
| 7 | NVO |
Novo Nordisk A S
|
116,291 | $5,574,990 | |
| 8 | GSK |
GSK plc
This page
|
41,025 | $2,150,530 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,150,530 | 41,025 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,840,365 | 33,346 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,430,104 | 29,162 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $891,254 | 20,650 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $870,067 | 22,658 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $877,461 | 22,650 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $852,264 | 25,200 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,117,577 | 27,338 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $979,825 | 25,450 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,287,900 | 30,042 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,090,008 | 29,412 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $955,985 | 26,372 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $984,091 | 27,612 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $923,407 | 25,953 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $911,988 | 25,953 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,807,157 | 197,321 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $28,386,962 | 664,890 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $28,402,681 | 664,800 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $23,945,015 | 553,600 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $16,889,849 | 450,680 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $16,937,843 | 433,687 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $15,181,105 | 433,687 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $15,717,141 | 435,457 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $16,253,105 | 440,257 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $17,595,284 | 439,807 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $16,143,655 | 434,407 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||